Trial Profile
A phase IIIb, open label observational study of SPD417 [carbamazepine] used in combination with other psychotropic medications for the treatment of bipolar I disorder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Nov 2005
Price :
$35
*
At a glance
- Drugs Carbamazepine (Primary)
- Indications Bipolar I disorders
- Focus Adverse reactions
- Sponsors Shire
- 02 Nov 2005 New trial record.